The expression profile of TMEM165 among the histological subtypes of invasive breast cancer indicate that TMEM165 expression occurs in all subtypes with the highest percentages in the ER negative subtypes (Table 2, IDC subtypes). Here, TMEM165 is linked to breast cancer.